Tyrosine Kinase(酪氨酸激酶)
- Bcr-Abl(64)
- Ack1(2)
- Axl(6)
- ALK(54)
- BMX Kinase(3)
- Broad Spectrum Protein Kinase Inhibitor(10)
- c-FMS(35)
- c-Kit(55)
- c-MET(82)
- c-RET(7)
- CSF-1R(3)
- DDR1/DDR2 Receptor(1)
- EGFR(225)
- EphB4(1)
- FAK(33)
- FGFR(94)
- FLT3(82)
- HER2(15)
- IGF1R(33)
- Insulin Receptor(42)
- IRAK(28)
- ITK(10)
- Lck(1)
- LRRK2(21)
- PDGFR(104)
- PTKs/RTKs(3)
- Pyk2(6)
- ROR(38)
- Spleen Tyrosine Kinase (Syk)(32)
- Src(95)
- Tie-2 (4)
- Trk(40)
- VEGFR(181)
- Discoidin Domain Receptor(15)
- DYRK(28)
- Ephrin Receptor(12)
- RET(28)
- ROS(14)
- TAM Receptor(28)
- IGFBR(1)
- Others(55)
- Cat.No. 产品名称 Information
-
GC32979
Chloropyramine hydrochloride
盐酸氯吡胺
Chloropyramine hydrochloride (Halopyramine) is a histamine receptor H1 antagonist and has anti-cholinergic, antispasmodic, and antiallergic effects. - GC32968 FLT3-IN-1 FF-10101 is a novel irreversible FLT3 inhibitor with ic50 of 0.20 nM and 0.16 nM for FLT3 (WT) and FLT3(D835Y), respectively.
- GC32963 hVEGF-IN-1 hVEGF-IN-1, a quinazoline derivative, specifically binds to the G-rich sequence in the internal ribosome entry site A (IRES-A) with a Kd of 0.928 μM, therefore destabilizes the G-quadruplex structure, , also hinders tumor cells migration and represses tumor growth by decreasing VEGF-A protein expression.
- GC32927 PF-06459988 PF-06459988是T790M-ContainingEGFRMutants不可逆性抑制剂。
-
GC32915
Pemigatinib
培米加替尼,INCB054828
An FGFR inhibitor -
GC32875
AZM475271 (M475271)
M475271
An inhibitor of c-Src kinase -
GC32867
Flumatinib (HHGV678)
4-[(4-甲基-1-哌嗪基)甲基]-N-[6-甲基-5-[[4-(3-吡啶基)-2-嘧啶基]氨基]-3-吡啶基]-3-(三氟甲基)苯甲酰胺,HHGV678
A Bcr-Abl inhibitor -
GC32864
Ensartinib hydrochloride (X-396 hydrochloride)
X-396 dihydrochloride
An ALK inhibitor -
GC32836
Naquotinib mesylate (ASP8273)
ASP8273 (mesylate)
An irreversible inhibitor of mutant EGFRs -
GC32835
PP58
PP58是吡啶[2,3-d]嘧啶化合物,抑制PDGFR,FGFR和Src家族活性的IC50值在纳摩尔级。
- GC32825 eCF506 An inhibitor of Src kinases
-
GC32819
Mirk-IN-1 (Dyrk1B/A-IN-1)
Dyrk1B/A-IN-1
Mirk-IN-1 (Dyrk1B/A-IN-1) 是一种有效的 Dyrk1B(Mirk kianse) 和 Dyrk1A 抑制剂,IC50 分别为 68±48 nM 和 22±8 nM。 -
GC32808
Selitrectinib (LOXO-195)
LOXO-195
A Trk kinase inhibitor -
GC32805
Sulfatinib (HMPL-012)
5-羟基-2-甲基吲哚,HMPL-012
A multi-kinase inhibitor - GC32802 PRN1371 An irreversible pan-FGFR inhibitor
- GC32797 AD80 AD80, a multikinase inhibitor, shows strong activity against human RET (c-RET), BRAF, S6K, and SRC but were much less active than either AD57 or AD58 against mTOR. The IC50 value for RET is 4 nM.
-
GC32769
MRX-2843 (UNC2371)
UNC2371
A Mer and FLT3 inhibitor -
GC32760
Dovitinib lactate (CHIR-258 lactate)
多韦替尼乳酸盐; CHIR-258 lactate; TKI-258 lactate
A multi-kinase inhibitor -
GC32752
TAS6417
TAS6417; CLN-081
TAS6417 (CLN-081, TPC-064) is a novel EGFR inhibitor that targets EGFR exon 20 insertion mutations while sparing wild-type (WT) EGFR. IC50 values ranges from 1.1 ± 0.1 to 8.0 ± 1.1 nmol/L. - GC32748 CA-4948 An IRAK-4 inhibitor
-
GC32733
Pyrotinib (SHR-1258)
吡咯替尼; SHR-1258
Pyrotinib (SHR-1258) (SHR-1258) 是一种有效的选择性 EGFR/HER2 双重抑制剂,IC50 分别为 13 和 38 nM。 -
GC32731
OSU-T315 (ILK-IN-1)
OSU-T315 analog
An ILK inhibitor -
GC32726
Tucatinib (Irbinitinib)
妥卡替尼,Irbinitinib; ARRY-380; ONT-380
An inhibitor of HER2 -
GC32713
Cintirorgon (LYC-55716)
LYC-55716
A ROR? agonist -
GC32703
Asciminib (ABL001)
ABL001
An allosteric inhibitor of Abl1 -
GC32625
KDR-in-4
KDR-in-4
KDR-in-4 (KDR-in-4) 是一种有效的激酶插入结构域受体 (KDR/VEGFR2) 抑制剂,IC50 为 7 nM。 - GC32623 CE-245677 CE-245677是一种有效的,可逆的Tie2和TrkA/B抑制剂,在细胞体系下,IC50值分别为4.7和1nM。
-
GC32502
Oglufanide (H-Glu-Trp-OH)
奥谷法奈; H-Glu-Trp-OH; L-Glutamyl-L-tryptophan
Oglufanide (H-Glu-Trp-OH) (H-Glu-Trp-OH) 是一种从小牛胸腺中分离出来的二肽免疫调节剂。 -
GC32469
SU5408 (VEGFR2 Kinase Inhibitor I)
VEGFR2 Kinase Inhibitor I
A potent, cell-permeable inhibitor of VEGFR2 -
GC32458
Trapidil (AR-12008)
唑嘧胺; AR-12008
An inhibitor of PDGF-induced activity and an antiplatelet agent -
GC19772
FLT3-IN-3
SAN50900
An FLT3 inhibitor -
GC32127
Alofanib (RPT835)
RPT835
An allosteric inhibitor of FGFR2 -
GC32100
Tarloxotinib bromide (TH-4000)
TH-4000
Tarloxotinib bromide (TH-4000)是一种不可逆的EGFR/HER2抑制剂前体。 - GC32053 GNE-4997 GNE-4997是一种有效且有选择性的ITK/TSK抑制剂。
-
GC32044
L 601920-0 (Methyl-3β-hydroxycholenate)
5-胆烯-24-酸-3Β-醇甲酯
L 601920-0 (Methyl-3β-hydroxycholenate) 是一种从专利 US20110263046 A1 中提取的 ROR γ 调节剂,如图 2 所示。 - GC31880 AZD-0284 AZD-0284是核受体RORγ的反向激动剂。在开发用于治疗寻常型斑块状银屑病和呼吸道疾病。
- GC31871 GNE-0946 GNE-0946是一个有效且有选择性的RORγ(RORc)拮抗剂,对HEK-293细胞的EC50值为4nM.
-
GC31842
GENZ-882706 (RA03546849)
RA03546849
GENZ-882706 (RA03546849) 是一种有效的集落刺激因子-1 受体 (CSF-1R) 抑制剂,提取自专利 WO 2017015267A1。 -
GC31819
PRT062607 (P505-15)
2-[[(1R,2S)-2-氨基环己基]氨基]-4-[[3-(2H-1,2,3-三唑-2-基)苯基]氨基]-5-嘧啶甲酰胺,P505-15; PRT-2607; BIIB-057
A potent, orally bioavailable Syk inhibitor - GC31816 ZK-261991 ZK-261991是一种可口服的VEGFR酪氨酸酶抑制剂,抑制VEGFR-2活性的IC50值为5nM。
-
GC31780
Pralsetinib (Blu667)
普拉替尼; BLU-667
Pralsetinib (BLU-667, CS 3009, Gavreto) is a highly potent and selective RET (c-RET) inhibitor with an IC50 of 0.4 nM for WT RET. It also demonstrates potent activity (IC50 0.4 nmol/L) against common oncogenic RET alterations, including RET (M918T).
-
GC31752
Tesevatinib (XL-647)
XL-647; EXEL-7647; KD-019
A multi-kinase inhibitor - GC31726 cFMS-IN-2 cFMS-IN-2是一种FMS激酶抑制剂,其IC50值为0.024μM。
-
GC31724
DDR1-IN-2
7rh
DDR1-IN-2 (DDR1-IN-2) 是一种盘状结构域受体 1 (DDR1) 的有效抑制剂,IC50 为 13.1 nM,对 DDR2 的抑制效果也较弱,IC50 为 203 nM。 -
GC31706
Ginsenoside Rg5
人参皂甙 Rg5
A ginsenoside with diverse biological activities -
GC31701
RK-24466 (KIN 001-51)
KIN 001-51
A selective inhibitor of lymphocyte-specific protein tyrosine kinase - GC31688 IRAK4-IN-1 IRAK4-IN-1 is an interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor with IC50 of 7 nM.
-
GC31676
Tavilermide (MIM-D3)
MIM-D3
他维勒胺 (MIM-D3) 是 TrkA 的选择性部分激动剂,或神经生长因子 (NGF) 模拟物。 -
GC31533
Vimirogant (VTP-43742)
(S)-N-((5-(乙基磺酰基)吡啶-2-基)甲基)-7-异丙基-6-(((1R,4S)-4-(三氟甲基)环己基)甲基)-6,7-二氢-5H-吡咯并[3,4-B]吡啶-3-甲酰胺,VTP-43742
Vimirogant (VTP-43742) (VTP-43742) 是一种有效的、选择性的和具有口服活性的 RORγt 抑制剂 (Ki=3.5 nM; IC50=17 nM)。 - GC31526 Insulin levels modulator Insulinlevelsmodulator可用于治疗糖尿病。